Results 121 to 130 of about 455 (134)

Antihistamine updosing reduces disease activity in difficult-to-treat cholinergic urticaria patients

2017
Antihistaminika der 2. Generation (sgAH) sind das Mittel der Wahl zur Behandlung der cholinergischen Urtikaria (CholU), einer speziellen Form der chronischen induzierbaren Urtikaria. Eine Vielzahl der CholU-Patienten leidet unter den charakteristischen Symptomen der Krankheit trotz Antihistaminika- Therapie in zugelassener Dosierung.
openaire   +1 more source

Antihistamine updosing in chronic urticaria - is there enough evidence?

British Journal of Dermatology, 2016
K, Weller, M, Maurer
openaire   +2 more sources

PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA MAY BENEFIT FROM LONGER TREATMENT OR UPDOSING WITH OMALIZUMAB

Annals of Allergy, Asthma & Immunology, 2022
G. Mosnaim, T. Casale, M. Holden, B. Trzaskoma, J. Bernstein   +4 more
openaire   +1 more source

Updosing of Nonsedating Antihistamines in Recalcitrant Chronic Urticaria

2018
Manjyot Gautam, Prachi Bhattar
openaire   +1 more source

Updosing Desloratadine Boosts Urticaria Response

Skin & Allergy News, 2010
openaire   +1 more source

CHANGES IN BASOPHIL ACTIVITY IN SUBJECTS ALLERGIC TO GRASS POLLEN DURING UPDOSING OF SUBCUTANEOUS IMMUNOTHERAPY

2010
Jump to…Top of pagePOS-FU-15Top of pageCHANGES IN BASOPHIL ACTIVITY IN SUBJECTS ALLERGIC TO GRASS POLLEN DURING UPDOSING OF SUBCUTANEOUS IMMUNOTHERAPYJohannes Martin Schmid, Ronald Dahl, Hans Juergen HoffmannDepartment of Respiratory Medicine, Århus University Hospital, AARHUS, DenmarkBackground: Subcutaneous Immunotherapy changes the immune response ...
Schmid, Johannes Martin; id_orcid 0000-0002-4558-2943, Dahl, Ronald, Hoffmann, Hans Jürgen; id_orcid 0000-0002-6743-7931   +2 more
openaire   +1 more source

Efficacy and tolerability of the updosing of second‐generation non‐sedating H1 antihistamines in children with chronic spontaneous urticaria

Pediatric Allergy and Immunology, 2021
Simona Barni, Lucrezia Sarti, Mattia Giovannini   +2 more
exaly  

Basophil Sensitivity Decreases During the Updosing of SCIT in Subjects Allergic to Grass Pollen

Journal of Allergy and Clinical Immunology, 2011
J.M. Schmid, R. Dahl, H.J. Hoffmann
openaire   +1 more source

Bilastine: a new H1‐antihistamine with an optimal profile for updosing in urticaria

Journal of the European Academy of Dermatology and Venereology, 2017
Martin Church
exaly  

Survey on the safety of a no-updosing regimen of sublingual immunotherapy.

European annals of allergy and clinical immunology, 2006
Musarra A, Cilia M, Pecora S, PASSALACQUA, GIOVANNI   +3 more
openaire   +2 more sources